Spravato, the brand name for esketamine, has a newly approved indication for treatment-resistant depression. tadamichi/Getty Images/iStockphoto/iStockphoto hide caption toggle caption…
Read More »antidepressant
Glioblastoma is a particularly aggressive brain tumour that at present is incurable. Cancer doctors can extend patients’ life expectancy through…
Read More »